openPR Logo
Press release

Nanosonics announces first authorised European distributors

12-01-2008 12:42 PM CET | Health & Medicine

Press release from: Nanosonics Europe GmbH

/ PR Agency: pluspool GmbH
Nanosonics announces first authorised European distributors

Hamburg, Germany, November 17: Nanosonics (ASX:NAN; FSE:OQS) has formally appointed its first exclusive distributors in Europe located in Germany, Austria, Switzerland, Italy, France and Scandinavia.

According to Nanosonics’ Director and CEO David Radford, this represents the achievement of another key milestone in the commercialisation of the company’s launch product, the Trophon EPR, scheduled for March 2009.

The Trophon EPR is an environmentally friendly device specifically designed to disinfect intracavity and surface ultrasound transducers. The product represents Nanosonics’ first commercial application of one of its core technologies, the NanoNebulant™ technology.
Compared to existing disinfection solutions, the Trophon EPR marks the beginning of a new level of disinfection: High Level Disinfection+, including sporicidal efficacy.

“We feel that there is strong demand for this unique product in ultrasound and infection control markets worldwide. The critical success factor will be the adoption of quality standards that provide for high level disinfection of ultrasound transducers. We are planning to overcome these challenges through beneficial cooperations with outstanding distribution partners in each country“, David Radford said.

Nanosonics is proceeding to establish a distribution infrastructure which will provide a sustainable competitive advantage for future growth. “The dealer contracts signed in Europe already commit a considerable increase well above our internal sales projections and consumables from these device sales will provide a secondary ongoing revenue stream”, David continued.

Further negotiations with well respected dealers located in other European, Asian and African countries are in progress and supposed to be successfully completed soon.

For more information about Nanosonics, the Trophon EPR and the NanoNebulant™ technology please visit the website http://www.nanosonics.eu/.

World Headquarters:

Nanosonics Ltd.
Unit 24, 566 Gardeners Road
Alexandria NSW 2015
Australia

www.nanosonics.com.au

European Headquarters:

Nanosonics Europe GmbH
Falkenried 88, House E
20251 Hamburg
Germany

www.nanosonics.eu

Media Contact Europe:

pluspool GmbH
Ballindamm 26
20095 Hamburg
Germany

nikola.heimann@plus-pool.de

About Nanosonics

The company is of Australian origin, located in Alexandria, Sydney, with European headquarters in Hamburg, Germany. Nanosonics is listed on the Australian Securities Exchange (NAN) and Frankfurt Stock Exchange (OQM) since 2007.

The company owns intellectual property relating to unique disinfection and sterilisation technologies which can be suited to a variety of markets including the healthcare industry, food processing, room and space decontamination and manufacturing.

Nanosonics is currently focused on developing infection control solutions for the global healthcare market. Initial applications are designed for the reprocessing of reusable medical instruments. The Trophon EPR is specifically designed to disinfect intracavity and surface ultrasound probes. Based on the NanoNebulant™ technology it surpasses the limitations of current methods by killing the most resilient micro-organisms, in a fast, safe and convenient way.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Nanosonics announces first authorised European distributors here

News-ID: 61185 • Views: 2448

More Releases from Nanosonics Europe GmbH

Ultrasound Transducer Disinfection in many Cases insufficient - New ‘Trophon E …
Hamburg, December 5, 2008: Current methods of ultrasound transducer disinfection are in many cases not sufficient for clinical practice. This is the latest alarming result issued by the Center for Disease Control and Prevention (CDC), the leading US public health agency, in its recently published Guideline for Disinfection and Sterilization in Healthcare Facilities (1). The guideline is the CDC’s response to the rapidly evolving epidemiology of hospital-acquired infections such

More Releases for European

23rd European Nephrology Conference
23rd European Nephrology Conference is the world’s leading conference for Nephrology professionals to gather and contribute their research for developing the new techniques in the field of Nephrology. Nephrology Conferences offers over 30 sessions from different areas in the field of Nephrology in the form of Keynote, Plenary and workshop sessions including oral and poster presentations. Nephrology Conferences which is going to be held in global & ancient city Rome, Italy
27th European Cardiology Conference
27th European Cardiology Conference Details: With the successful completion of 20th European Cardiology Conference, the Cardiology Conferences in 2018 meet is proud to announce that its 3 day 27th European Cardiology Conference (Euro Cardiology 2018) will be held in Rome, Italy during October 22-24, 2018.The conference will be the world’s best platform for all the cardiologists, cardiac surgeons, medical practitioners, research scholars and clinical research organizations to encourage and explore the modern
European Grape Market 2017
Apex Research, recently published a detailed market research study focused on the "European Grape Market" across the global, regional and country level. The report provides 360° analysis of "European Grape Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global European Grape industry, and estimates the future trend of European Grape market on
4th European Biopharma Congress
Biopharmaceuticals Conference Series Conference Series has been instrumental in conducting international Biopharmaceuticals meetings for several years, and very excited to expand Europe, America and Asia Pacific continents. Previous meetings were held in major cities like San Francisco, Baltimore, with success the meetings again scheduled in continents. 4th European Biopharma Congress, is scheduled to be held during November 09-11, 2017; at Vienna, Austria. The opportunity in biopharmaceuticals is big and growing too
20th European Cardiology Conference
Euro Cardiology 2017 invites all the cardiologists, Scientists, Professors, Research scholars, Industrial Professionals, Cardiac surgeons at 20th European Cardiology Conference is going to be held in Budapest, Hungary during October 16-18, 2017. With the support of Euro Cardiology 2016 Organizing Committee Members, the CME accredited 20th European Cardiology Conference is scheduled to be held in Budapest, Hungary during October 16-18, 2017. Cardiology Conferences will lay a platform for world-class professors, cardiologists
18th European Diabetes Congress
It takes us immense pleasure to announce the conference that 18th European Diabetes Congress which is going to be held during July 17-18, 2017 at Lisbon, Portugal. Euro Diabetes 2017 conference will focus on the latest and exciting innovations in all areas of Diabetes research which offers a unique opportunity for investigators across the globe to meet, network, and perceive new scientific innovations. This year’s annual congress highlights the theme, “Diabetes